FDA Approves New Use for Micardis in Cardiovascular Risk Reduction and Twynsta as New Combination Treatment for High Blood Pressure

http://www.therapeuticsdaily.com/news/article.cfm?contentvalue=1937748&contenttype=sentryarticle&channelID=26

Comments are closed.